RoutineMetric
Corporate Governance & M&A

Delaware DGCL § 204 & § 205 Ratification Planner

Evaluate corporate defects, analyze over-issuance scenarios, calculate notice and litigation challenge deadlines under Delaware General Corporation Law Sections 204 & 205, and generate board minutes.

Defect Configuration

Date defect occurred
Section 204 adoption date

Putative Stock Capitalization Reconciliation

Reconciliation StatusHistorically Over-Issued
Defect Total Outstanding
5,300,000
Historical Capital Margin
-300,000

Section 205 Judicial Petition Risk Factors

While Section 204 is a robust self-help route, certain factors mandate or highly advise filing a Section 205 petition to the Delaware Court of Chancery for judicial ratification. Check all that apply:

Statutory Cure Path

DGCL Section 204
Section 204 Self-Help ViableThe board is functional and stockholders are cooperative. You can proceed with standard board adoption, optional stockholder meeting, and Certificate of Validation filings without costly Court of Chancery litigation.

Proceed with adopting Section 204 board resolutions, mailing stockholder notices, and compiling filings.

Statutory Timelines

204(g) Notice MailingStrict 20-Day Limit
Mail Notice No Later Than:
August 26, 2026
Exactly 20 calendar days prior to the September 15, 2026 stockholder meeting.
Challenge Window (205(f))120-Day Limit
Litigation Expiration Date:
January 16, 2027
152 days remaining
Cure becomes legally unchallengeable 120 days after the later of stockholder notice or validation filing (September 18, 2026).

Court Likelihood of Validation

Weighted Validation Score86%
1. Board Good Faith Belief85/100
2. Stockholder Reliance90/100
3. Absence of Harm (Validated)85/100
4. Avoidance of Injustice90/100
Cure Plan AssembledStatutory dates, mathematical over-issuances, and court likelihood values reconciled. Export report below.
Statutory Board Resolutions Minutes Draft
RESOLVED, that the defective corporate act of the Corporation consisting of the over-issuance of 500,000 shares of Common Class A on or about June 15, 2025 (the "Defective Corporate Act"), which was void or voidable due to a failure of authorization, is hereby approved, ratified, and validated in all respects pursuant to Section 204 of the Delaware General Corporation Law (the "DGCL"); and

RESOLVED FURTHER, that the board hereby approves and ratifies the following details regarding the Defective Corporate Act:
1. Date of the Defective Act: June 15, 2025
2. Nature of the Failure of Authorization: Stock issued in excess of the Corporation's authorized limit in its Certificate of Incorporation.
3. Putative Stock to be Ratified: 500,000 shares of Common Class A
4. Date of Putative Issuance: June 15, 2025

RESOLVED FURTHER, that the officers of the Corporation be, and each of them hereby is, authorized, empowered, and directed in the name and on behalf of the Corporation to prepare, execute, and file a Certificate of Validation with the Secretary of State of the State of Delaware in accordance with Section 204(e) of the DGCL; and

RESOLVED FURTHER, that notice of this board ratification be given to all current and historical stockholders entitled thereto under Section 204(g) of the DGCL.
Advertisement
Bottom Banner Ad (728x90)

Statutory Guide to Delaware DGCL § 204 & § 205: Curing Failure of Authorization & Putative Stock

Under traditional Delaware common law, a severe distinction was drawn between corporate acts that were "void" versus those that were "voidable." A voidable act is one taken within the powers of the corporation but failing to conform to internal procedures (such as an officer signing an unauthorized contract), which stockholders can subsequently ratify. A void act, by contrast, is one that the corporation lacked the legal power to perform under its charter or the Delaware General Corporation Law (DGCL)—most notably, the over-issuance of stock beyond charter limits or a merger executed in violation of statutory vote requirements.

Historically, Delaware courts held that void corporate acts could **never** be retroactively validated or ratified, even by a unanimous vote of stockholders. This meant that if a corporation discovered an over-issuance of stock from its early venture-backed rounds during an IPO or M&A exit, the corporation had no choice but to negotiate complex, high-risk settlement releases or attempt to restructure its capital from scratch. To provide a clear statutory remedy to this commercial bottleneck, Delaware enacted **Sections 204 and 205 of the DGCL**, creating a revolutionary, dual-track path to cure corporate defects.

1. Section 204: The Self-Help Board & Stockholder Ratification Procedure

Section 204 provides a cooperative, internal "self-help" procedure that a corporation can implement unilaterally if it has a functioning board of directors and cooperative stockholders. The process requires strict adherence to statutory steps:

  • Board Adoption: The board of directors must adopt formal resolutions identifying the defective act, the nature of the authorization failure, the number and class of putative stock, and that the board approves the ratification.
  • Stockholder Vote: If the original act required a stockholder vote (or if the act is an issuance of putative stock that requires a charter amendment), a stockholder vote of the outstanding shares at the time of ratification must be secured. Under Section 204(d), the voting thresholds match those required at the time of the original defective act or at the time of ratification, whichever is higher.
  • Stockholder Notice: Under Section 204(g), notice of the ratification must be mailed to all current stockholders and all holders of putative stock as of the date of the historical defect. This notice must be sent at least 20 days prior to any stockholder vote, or promptly after board adoption if no vote is required.
  • Certificate of Validation: If the defective act required a filing with the Delaware Secretary of State (such as a Certificate of Incorporation amendment or a merger certificate), the corporation must file a "Certificate of Validation" under Section 204(e) to retroactively seal the public record.

2. Section 205: Judicial Remedies in the Delaware Court of Chancery

When the cooperative self-help path under Section 204 is unavailable or too risky, Section 205 empowers the corporation, any director, any record or beneficial stockholder (including putative holders), or any party claiming substantial and adverse affection to petition the Court of Chancery.

The Court has broad equitable power to determine the validity of any corporate act or stock. In deciding whether to validate a defective act, Section 205(d) mandates that the Court examine five key factors:

  1. Whether the defective corporate act was originally performed in the good faith belief of the board, officers, or stockholders that it was fully authorized.
  2. Whether the corporation and board have treated the act or putative stock as valid, and whether subsequent buyers or third parties relied on its validity.
  3. Whether any person (especially creditors or stockholders) would be harmed or prejudiced if the act is validated.
  4. Whether any person would be harmed or prejudiced if the act is **not** validated (e.g., whether stockholders would lose the value of their investments).
  5. Any other factor the Court deems just and equitable to prevent injustice.

3. When to Bypass Section 204 and File a Section 205 Petition

Although Section 204 is designed to avoid court expenses, there are several vital scenarios where general counsels and transaction advisors should bypass Section 204 and head straight to court under Section 205:

  • The 120-Day Challenge Period (Section 205(f)): Under Section 205(f), any shareholder has up to 120 days from the effective date of a Section 204 ratification to file a lawsuit in the Court of Chancery challenging the cure. In high-stakes M&A or IPO scenarios where closing is scheduled in days, a company cannot wait out a 120-day litigation challenge period. Section 205 judicial decrees provide **instant, final validation** that cannot be challenged.
  • Voter Deadlocks or Activist Blocks: If a stockholder vote is required but a major activist shareholder or founder refuses to approve the Section 204 ratification, the board can use Section 205 to ask the court to validate the act over the stockholder's objection, citing reliance and good faith.
  • Lack of a Functional Board: If a startup's board is deadlocked or there is a dispute over which directors were validly elected, no board can pass the mandatory Section 204 board resolutions. The court can resolve the deadlock and ratify the act under Section 205 directly.

4. Professional Case Law Precedents

Delaware courts have rigorously established the boundaries of Section 204 and 205 validation:

  • In re Numoda Corp. (2015): The Court of Chancery confirmed that Section 205 cannot be used to "invent" transactions that never occurred. There must be a clear "defective corporate act" that was attempted but failed due to technical compliance issues, not merely a vague handshake agreement.
  • In re Fusion-io, Inc. (2018): The court validated stockholder votes and option grants under Section 205 where technical errors in record dates or bylaws would have otherwise invalidated hundreds of employee grants.
  • In re Lordstown Motors Corp. (2023): Following a massive wave of SPAC-related litigation where companies realized they had failed to hold separate class votes for charter amendments increasing authorized shares under Section 242(b)(2), the Court of Chancery issued rapid Section 205 orders validating the capital structures of dozens of public companies, protecting public markets from severe disruption.
Advertisement